Well Lead Medical Co., Ltd. (603309.SS)
CNY 11.91
(-0.25%)
CNY 11.91
(-0.25%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 1.37 Billion CNY | 0.63% |
| 2022 | 1.36 Billion CNY | 21.88% |
| 2021 | 1.11 Billion CNY | -1.07% |
| 2020 | 1.13 Billion CNY | 13.77% |
| 2019 | 993.81 Million CNY | 33.25% |
| 2018 | 745.83 Million CNY | 18.41% |
| 2017 | 629.89 Million CNY | 22.21% |
| 2016 | 515.41 Million CNY | -6.09% |
| 2015 | 548.87 Million CNY | 10.57% |
| 2014 | 496.41 Million CNY | 13.55% |
| 2013 | 437.16 Million CNY | 12.9% |
| 2012 | 387.22 Million CNY | 11.2% |
| 2011 | 348.23 Million CNY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q3 | 384.17 Million CNY | 5.76% |
| 2024 Q1 | 305.13 Million CNY | -24.89% |
| 2024 Q2 | 363.25 Million CNY | 19.05% |
| 2023 Q3 | 325.12 Million CNY | 11.95% |
| 2023 Q2 | 290.41 Million CNY | -19.68% |
| 2023 FY | 1.37 Billion CNY | 0.63% |
| 2023 Q1 | 361.57 Million CNY | 0.74% |
| 2023 Q4 | 406.27 Million CNY | 24.96% |
| 2022 FY | 1.36 Billion CNY | 21.88% |
| 2022 Q3 | 374.31 Million CNY | 13.7% |
| 2022 Q2 | 329.21 Million CNY | 9.4% |
| 2022 Q1 | 300.91 Million CNY | -14.88% |
| 2022 Q4 | 358.9 Million CNY | -4.12% |
| 2021 Q4 | 353.52 Million CNY | 21.08% |
| 2021 Q1 | 219.88 Million CNY | -23.83% |
| 2021 FY | 1.11 Billion CNY | -1.07% |
| 2021 Q2 | 253.18 Million CNY | 15.14% |
| 2021 Q3 | 291.97 Million CNY | 15.32% |
| 2020 Q4 | 288.69 Million CNY | -1.52% |
| 2020 Q2 | 392.74 Million CNY | 151.6% |
| 2020 Q1 | 156.09 Million CNY | -44.81% |
| 2020 FY | 1.13 Billion CNY | 13.77% |
| 2020 Q3 | 293.14 Million CNY | -25.36% |
| 2019 Q2 | 260.86 Million CNY | 35.13% |
| 2019 FY | 993.81 Million CNY | 33.25% |
| 2019 Q1 | 193.04 Million CNY | -21.54% |
| 2019 Q4 | 282.85 Million CNY | 10.04% |
| 2019 Q3 | 257.05 Million CNY | -1.46% |
| 2018 Q2 | 186.48 Million CNY | 43.63% |
| 2018 Q3 | 183.48 Million CNY | -1.61% |
| 2018 Q4 | 246.03 Million CNY | 34.09% |
| 2018 FY | 745.83 Million CNY | 18.41% |
| 2018 Q1 | 129.83 Million CNY | -28.68% |
| 2017 FY | 629.89 Million CNY | 22.21% |
| 2017 Q4 | 182.04 Million CNY | 14.12% |
| 2017 Q3 | 159.51 Million CNY | -7.41% |
| 2017 Q1 | 116.06 Million CNY | -22.95% |
| 2017 Q2 | 172.27 Million CNY | 48.43% |
| 2016 Q1 | 100.32 Million CNY | -36.7% |
| 2016 Q4 | 150.64 Million CNY | 9.95% |
| 2016 FY | 515.41 Million CNY | -6.09% |
| 2016 Q3 | 137 Million CNY | 7.51% |
| 2016 Q2 | 127.44 Million CNY | 27.03% |
| 2015 Q3 | 146.65 Million CNY | -0.69% |
| 2015 Q1 | 96.05 Million CNY | -32.37% |
| 2015 FY | 548.87 Million CNY | 10.57% |
| 2015 Q4 | 158.49 Million CNY | 8.07% |
| 2015 Q2 | 147.66 Million CNY | 53.74% |
| 2014 Q2 | 145.81 Million CNY | 64.71% |
| 2014 Q4 | 142.03 Million CNY | 18.33% |
| 2014 Q1 | 88.53 Million CNY | 0.0% |
| 2014 FY | 496.41 Million CNY | 13.55% |
| 2014 Q3 | 120.03 Million CNY | -17.68% |
| 2013 FY | 437.16 Million CNY | 12.9% |
| 2012 FY | 387.22 Million CNY | 11.2% |
| 2011 FY | 348.23 Million CNY | 0.0% |